Position in TAK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,051,359
+$383,624 QoQ
Shares Held
65,587
+53.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#98
of 375 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Entropy Technologies, LP holds $12,221,526 across 9 Drug Manufacturers - Specialty & Generic names. TAK ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
74,893 | $5,381,810 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
16,909 | $2,849,842 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
12,707 | $1,409,714 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
65,587 | $1,051,359 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
13,298 | $618,489 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
3,282 | $271,683 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
29,180 | $231,105 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
6,310 | $228,422 |
All Filings in TAK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,051,359 | 65,587 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $667,735 | 42,831 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $308,538 | 21,075 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $155,882 | 10,483 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||